Administration Shares Regulatory Priorities for 2020
The Trump administration’s health care regulatory priorities for 2020 have been outlined by the Office of Management and Budget in a newly released “Statement of Regulatory Priorities for Fiscal Year 2020.”
The statement, an annual OMB document, organizes the priorities as follows:
- Facilitating patient-centered markets
- Fixing health care financing through protecting private insurance and Medicare
- Fixing health care financing through reforming the individual market
- Fixing health care financing through making the ACA and Medicaid fiscally sustainable
- Bringing value to health care through price and quality transparency
- Bringing value to health care through patient-centered health IT
- Bringing value to health care through deregulation, especially for coordinated care
- Bringing value to health care through tackling the high cost of prescription drugs
- Bringing value to health care through accelerated drug and device approval and reimbursement
- Promoting health and protecting life
- Addressing impactable health challenges: kidney health
- Addressing impactable health challenges: combatting the opioid crisis
- Protecting conscience and life at all stages
- Reducing the disease and death associated with tobacco use
- Promoting independence
- Returning TANF to promoting work, marriage and family
- Supporting adoption
- Empowering Americans to improve their nutrition
- Promoting flexibility for states, grantees, and regulated entities
Learn more about the regulatory directions the administration intends to take for the rest of its 2020 fiscal year in the newly released “Statement of Regulatory Priorities for Fiscal Year 2020.” Go here to see the complete list of regulations that the Department of Health and Human Services intends to pursue in FY 2020, including 55 by the Centers for Medicare & Medicaid Services (CMS).
According to the Centers for Medicare & Medicaid Services, the Medicaid improper payment rate in FY 2019 was 14.9 percent, amounting to $57.36 billion in improper payments. The improper payment rate that year for CHIP services was 15.83 percent, representing $2.74 billion in improper payments. Both are significant increases over FY 2018, when the Medicaid improper payment rate was 9.7 percent, representing $36.25 billion, and the CHIP rate was 8.57 percent, for $1.39 billion.
While DHS’s area of endeavor is broad and goes beyond health care, Medicaid is an important aspect of its work and that importance is reflected in the plan, which includes descriptions of DHS’s ambitions in the following areas:
Included in this month’s edition are articles about:
The report presents information on hospital volume and outcomes for 17 different medical conditions and surgical procedures from October 2017 through September 2018. It also compares hospital performance over the five-year period from 2013 through 2018 on an aggregate state-wide basis and for individual hospitals.
The report includes:
Specifically, they experienced:
The Medicaid DSH cut was included in the 2010 health care reform law in anticipation of a great reduction in the number of uninsured people leaving hospitals providing much less uncompensated care and therefore not in need of as much DSH money. The law’s reach has not proven to be as great as anticipated, however, and two developments since the law’s passage have put a damper on the expected rise in the number of insured Americans: a court decision that made it optional for states to expand their Medicaid program and the repeal of the requirement that everyone purchase health insurance.
As reported by Kaiser Health News,